“Processed Lentil Seed Powder As a Potential Matrix Base for Nutraceutical Tablets”. Journal of Carcinogenesis, vol. 23, no. 1, Sept. 2025, pp. 152-6, https://doi.org/10.64149/J.Carcinog.24.3.541-551.